Mode
Text Size
Log in / Sign up
N/A Completed N=200 Randomized Single-blind Treatment

Technology Intensified Diabetes Education Study in African Americans

Type 2 Diabetes Mellitus · Diabetes Mellitus, Adult-Onset · Diabetes Mellitus, Non-Insulin-Dependent · Diabetes Mellitus, Noninsulin Dependent
Source: ClinicalTrials.gov NCT02088658 ↗
Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Hemoglobin A1c — 9.8; 9.6 mean percent of HbA1c

Summary

The purpose of this study is to test the usefulness of an intervention that combines technology with diabetes education and skills training. This study has been designed specifically for African Americans with poorly controlled type 2 diabetes.

Outcome Measures

OutcomeResultp-value
PRIMARY
Hemoglobin A1c
9.8; 9.6

Eligibility Criteria

Inclusion Criteria

  • Age ≥21 years
  • Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
  • Self-identified as AA
  • Subject must be willing to use the FORA monitoring system for 12 months
  • Subjects must be able to communicate in English
  • Subjects must have access to a telephone (landline for data uploads) for the study period

Exclusion Criteria

  • Mental confusion on interview suggesting significant dementia
  • Participation in other diabetes clinical trials
  • Alcohol or drug abuse/dependency
  • Active psychosis or acute mental disorder
  • Life expectancy <12 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02088658). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search